Response to: ‘High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?’ by Inancet al

医学 抗磷脂综合征 免疫学 痹症科 结缔组织病 皮肤病科 内科学 自身免疫性疾病 抗体
作者
James Cheng‐Chung Wei,Fang Xiao Zhu,Jing‐Yang Huang
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:81 (7): e111-e111 被引量:1
标识
DOI:10.1136/annrheumdis-2020-218402
摘要

Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et alWe thank Inanc et al 1 for their comments on our article entitled 'Risk of systemic lupus erythematosus (SLE) in patients with idiopathic thrombocytopenic purpura (ITP): a population-based cohort study'.In our article, we concluded that ITP is strongly associated with incidental SLE. 2 We agree with Inanc et al 1 that antiphospholipid syndrome (APS) is an important effect modifier in ITP and SLE.We also acknowledge that Inanc et al 1 addressed the difference of APS (2.77% in the ITP group vs 0.02% in the non-ITP controls) in table 1 of our article. 2Actually, ITP, APS and SLE sometimes overlapped in clinical practice.As in table 1, there are more baseline comorbidities in the ITP group, including thrombotic event, cardiovascular disease and ITP.Hence, we did propensity score to match these differences rather than exclude these comorbidities in patient selection as in figure 1.The reason for this is that once you exclude these effect modifiers, then you cannot study their effects.Thus, we prefer matching and stratified analysis on important effect modifiers, rather than exclusion. 3s Inanc et al 1 mentioned, many claim-based or patientreported databases have concerns of validity and uncertainty.Unfortunately, the National Taiwan Insurance Research Database (NHIRD) did not provide laboratory data, such as antinuclear antibody (ANA) and APS profiles.Although this is a limitation, the NHIRD had been validated and appreciated in many high impact publications. 4 5 In our study, we had tried to minimise this information bias by adding sensitivity tests and also stratifies analysis on important confounders, such as thrombosis cardiovascular disease and some infections and life stylerelated diseases to reduce the bias from comorbidities, including APS.These had been discussed in-depth in Discussion section of our article.We agree that APS clinical features and laboratory profiles and ANA are important baseline evaluation for every patient with ITP.It is also indeed our study purpose and conclusion.Furthermore, even though baseline ANA and aPL were negative, we suggest that patients with ITP should still be monitored yearly for clinical and serological lupus or APS.We hope this clinical application will improve the quality of our daily practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
kd完成签到,获得积分10
1秒前
2秒前
xiaoma发布了新的文献求助10
3秒前
realtimes发布了新的文献求助10
3秒前
shinn发布了新的文献求助10
3秒前
4秒前
百合子发布了新的文献求助10
4秒前
FRANKFANG发布了新的文献求助10
5秒前
zy7227发布了新的文献求助10
6秒前
执念发布了新的文献求助20
7秒前
dinghaifeng发布了新的文献求助10
7秒前
7秒前
jie酱拌面完成签到,获得积分10
8秒前
Shoujiang发布了新的文献求助10
9秒前
xiaoma完成签到,获得积分10
9秒前
9秒前
量子星尘发布了新的文献求助10
10秒前
10秒前
10秒前
华仔应助shinn采纳,获得10
11秒前
xuzb完成签到,获得积分10
11秒前
13秒前
姚大帅发布了新的文献求助10
14秒前
15秒前
dinghaifeng完成签到,获得积分10
15秒前
乐乐应助随风走采纳,获得10
15秒前
Akim应助kassidy采纳,获得10
16秒前
呱呱呱呱呱呱完成签到 ,获得积分10
17秒前
单纯菠萝发布了新的文献求助10
17秒前
烟花应助hd采纳,获得10
18秒前
18秒前
阿良完成签到,获得积分10
19秒前
19秒前
20秒前
狂野的钻石完成签到 ,获得积分10
20秒前
研友_Z6eOgn发布了新的文献求助10
21秒前
华仔应助英勇的人生采纳,获得10
21秒前
21秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975375
求助须知:如何正确求助?哪些是违规求助? 3519700
关于积分的说明 11199305
捐赠科研通 3256034
什么是DOI,文献DOI怎么找? 1798049
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305